Is surgery necessary in stage III and stage IV cancer of the head and neck that responds to induction chemotherapy?

Archives of Otolaryngology - Head and Neck Surgery

Volumn 122, Issue 5, 1996, Pages 467-471

  Poulsen, Michael ^a   Aldren, Chris ^c   Tripcony, Lee ^a,b   Walker, Quenten ^a  

^a Queensland Radium Institute   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; METHOTREXATE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; HYPOPHARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

EID: 0029928948     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1996.01890170003001     Document Type: Article

References (17)

1. Taylor S Integration of chemotherapy into the combined modality therapy of head and neck squamous cancer, Int J Radiat Oncol Biol Phys. 1986;13:779-783.
2. Stell P, Rawson N. Adjuvant chemotherapy in head and neck cancer Br J Cancer. 1990;61:779-787.
3. Jacobs C, Goffinet D, Goffinet L, Kohler M, Fee W. Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer: a report from the Northern California Oncology Group Cancer 1987;60 1178-1183
4. Veterans Affairs Laryngeal Cancer Study Group, V. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-1690
5. Price L, Hill B A kinetically based logical approach to chemotherapy of head and neck cancer. Clin Oncol. 1977;2:339-345.
6. Kaplan E, Meier P. Non-parametric estimation for incomplete observation. J Am Stat Assoc 1955;53:457-451.
7. Rosenthal D, Pistenmaa D, Glatstein E. A review of neoadjuvant chemotherapy for head and neck cancer, partially shrunken tumors may be both leaner and meaner. Int J Radiat Oncol Biol Phys 1993;28:315-320.
8. Fletcher GH. Elective irradiation of subclinical disease in cancers of the head and neck. Cancer. 1972;29 1450-1454
9. Tannock I Browman, G. Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer. J Clin Oncol. 1986;4:1121-1126.
10. Withers H, Taylor J, Maciejewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol. 1988;27:131-146.
11. Fowler JF. Brief summary of radiobiological principles in fractionated radiotherapy Semin Radiat Oncol 1992;2:16-21
12. Turner S, Kalinis I, Gebski V, Tiver K. Locally advanced (stage III and IV) head and neck cancer: Westmead Hospital Experience. Aust N Z J Surg. 1991;61 744-752.
13. Kish J, Drelichman A, Jacobs J, et al Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck Cancer Treat Rep 1982;66:471-474.
14. Smith I, Poulsen M, Jackson M, Robinson D, Thomson D, Coman W. Triple therapy for advanced squamous cell carcinoma of the head and neck. Aust N Z J Surg. 1992;62:373-381.
15. Brunin F, Rodriguez J, Jaulerry C, et al. Induction chemotherapy in advanced head and neck cancer, preliminary results of a randomized study. Acta Oncol. 1989;28:61-65
16. Merlano M, Vitale V, Rosso R, et al. Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992;327:1115-1121.
17. Poulsen M New concepts in radiotherapy for advanced squamous cell carcinoma of the head and neck Aust N Z J Surg 1992;62:702-708.